Ligands located within a cholesterol domain enhance gene delivery to the target tissue

Journal of Controlled Release

Volumn 160, Issue 1, 2012, Pages 57-63

  Xu, Long ^a   Betker, Jamie ^a   Yin, Hao ^a   Anchordoquy, Thomas J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cholesterol domain; Folate; Ligand microenvironment; Nanodomain; Targeted gene delivery in vivo; Tumor targeting

Indexed keywords

FOLATE; IN-VIVO; MICROENVIRONMENTS; NANODOMAIN; TUMOR TARGETING;

CHOLESTEROL; GENE TRANSFER; LIPOSOMES; MOLECULAR BIOLOGY; TUMORS;

LIGANDS;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CHOLESTEROL; FOLIC ACID; LIPOPLEX; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENE EXPRESSION; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TUMOR XENOGRAFT;

ANIMALS; CHOLESTEROL; DNA; DRUG CARRIERS; FOLIC ACID; GENE TRANSFER TECHNIQUES; HUMANS; KB CELLS; LIGANDS; LIPOSOMES; LUCIFERASES, FIREFLY; MICE; MICE, NUDE; PLASMIDS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861528603     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.03.003     Document Type: Article

References (46)

1. M. Cavazzana-Calvo, S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J.L. Casanova, P. Bousso, F.L. Deist, and A. Fischer Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672
2. S.C. Hyde, K.W. Southern, U. Gileadi, E.M. Fitzjohn, K.A. Mofford, B.E. Waddell, H.C. Gooi, C.A. Goddard, K. Hannavy, S.E. Smyth, J.J. Egan, F.L. Sorgi, L. Huang, A.W. Cuthbert, M.J. Evans, W.H. Colledge, C.F. Higgins, A.K. Webb, and D.R. Gill Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis Gene Ther. 7 2000 1156 1165
3. G.J. Nabel, E.G. Nabel, Z.Y. Yang, B.A. Fox, G.E. Plautz, X. Gao, L. Huang, S. Shu, D. Gordon, and A.E. Chang Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans Proc. Natl. Acad. Sci. U. S. A. 90 1993 11307 11311
4. N.P. Restifo, H. Ying, L. Hwang, and W.W. Leitner The promise of nucleic acid vaccines Gene Ther. 7 2000 89 92
5. L.G. Barron, L. Gagne, and F.C. Szoka Jr. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration Hum. Gene Ther. 10 1999 1683 1694
6. F. Liu, H. Qi, L. Huang, and D. Liu Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration Gene Ther. 4 1997 517 523
7. R.I. Mahato, K. Kawabata, Y. Takakura, and M. Hashida In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes J. Drug Target. 3 1995 149 157
8. L. Mohr, S.K. Yoon, S.J. Eastman, Q. Chu, R.K. Scheule, P.P. Scaglioni, M. Geissler, T. Heintges, H.E. Blum, and J.R. Wands Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice Hum. Gene Ther. 12 2001 799 809
9. G. Osaka, K. Carey, A. Cuthbertson, P. Godowski, T. Patapoff, A. Ryan, T. Gadek, and J. Mordenti Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach J. Pharm. Sci. 85 1996 612 618
10. Y.K. Song, F. Liu, S. Chu, and D. Liu Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration Hum. Gene Ther. 8 1997 1585 1594
11. A.R. Thierry, P. Rabinovich, B. Peng, L.C. Mahan, J.L. Bryant, and R.C. Gallo Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA Gene Ther. 4 1997 226 237
12. H.M. Patel Serum opsonins and liposomes: their interaction and opsonophagocytosis Crit. Rev. Ther. Drug Carrier Syst. 9 1992 39 90
13. P.R. Cullis, A. Chonn, and S.C. Semple Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo Adv. Drug Deliv. Rev. 32 1998 3 17
14. J.A. Kamps, and G.L. Scherphof Receptor versus non-receptor mediated clearance of liposomes Adv. Drug Deliv. Rev. 32 1998 81 97
15. T. Ishida, H. Harashima, and H. Kiwada Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors Curr. Drug Metab. 2 2001 397 409
16. L. Xu, C.C. Huang, W. Huang, W.H. Tang, A. Rait, Y.Z. Yin, I. Cruz, L.M. Xiang, K.F. Pirollo, and E.H. Chang Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes Mol. Cancer Ther. 1 2002 337 346
17. E. Bruckheimer, P. Harvie, J. Orthel, B. Dutzar, K. Furstoss, E. Mebel, P. Anklesaria, and R. Paul In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma Cancer Gene Ther. 11 2004 128 134
18. P. Harvie, B. Dutzar, T. Galbraith, S. Cudmore, D. O'Mahony, P. Anklesaria, and R. Paul Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs J. Liposome Res. 13 2003 231 247
19. C. Mamot, D.C. Drummond, C.O. Noble, V. Kallab, Z. Guo, K. Hong, D.B. Kirpotin, and J.W. Park Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo Cancer Res. 65 2005 11631 11638
20. M.E. Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic Mol. Pharm. 6 2009 659 668
21. C.A. Fernandez, and K.G. Rice Engineered nanoscaled polyplex gene delivery systems Mol. Pharm. 6 2009 1277 1289
22. S.D. Li, S. Chono, and L. Huang Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles J. Control. Release 126 2008 77 84
23. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 2008 496 504
24. D.B. Kirpotin, D.C. Drummond, Y. Shao, M.R. Shalaby, K. Hong, U.B. Nielsen, J.D. Marks, C.C. Benz, and J.W. Park Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 2006 6732 6740
25. R.A. Dewey, G. Morrissey, C.M. Cowsill, D. Stone, F. Bolognani, N.J. Dodd, T.D. Southgate, D. Klatzmann, H. Lassmann, M.G. Castro, and P.R. Lowenstein Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials Nat. Med. 5 1999 1256 1263
26. J.L. Fox Gene-therapy death prompts broad civil lawsuit Nat. Biotechnol. 18 2000 1136
27. A. Akinc, A. Zumbuehl, M. Goldberg, E.S. Leshchiner, V. Busini, N. Hossain, S.A. Bacallado, D.N. Nguyen, J. Fuller, R. Alvarez, A. Borodovsky, T. Borland, R. Constien, A. de Fougerolles, J.R. Dorkin, K. Narayanannair Jayaprakash, M. Jayaraman, M. John, V. Koteliansky, M. Manoharan, L. Nechev, J. Qin, T. Racie, D. Raitcheva, K.G. Rajeev, D.W. Sah, J. Soutschek, I. Toudjarska, H.P. Vornlocher, T.S. Zimmermann, R. Langer, and D.G. Anderson A combinatorial library of lipid-like materials for delivery of RNAi therapeutics Nat. Biotechnol. 26 2008 561 569
28. P. Harvie, F.M. Wong, and M.B. Bally Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles J. Pharm. Sci. 89 2000 652 663
29. Z. Hyvonen, S. Ronkko, M.R. Toppinen, I. Jaaskelainen, A. Plotniece, and A. Urtti Dioleoyl phosphatidylethanolamine and PEG-lipid conjugates modify DNA delivery mediated by 1,4-dihydropyridine amphiphiles J. Control. Release 99 2004 177 190
30. F. Shi, L. Wasungu, A. Nomden, M.C. Stuart, E. Polushkin, J.B. Engberts, and D. Hoekstra Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions Biochem. J. 366 2002 333 341
31. T.K. Armstrong, L.G. Girouard, and T.J. Anchordoquy Effects of PEGylation on the preservation of cationic lipid/DNA complexes during freeze-thawing and lyophilization J. Pharm. Sci. 91 2002 2549 2558
32. Y. Zhang, E.L. Bradshaw-Pierce, A. Delille, D.L. Gustafson, and T.J. Anchordoquy In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation J. Pharm. Sci. 97 2008 237 250
33. Y. Zhang, and T.J. Anchordoquy The role of lipid charge density in the serum stability of cationic lipid/DNA complexes Biochim. Biophys. Acta 1663 2004 143 157
34. L. Xu, and T.J. Anchordoquy Cholesterol domains in cationic lipid/DNA complexes improve transfection Biochim. Biophys. Acta 1778 2008 2177 2181
35. L. Xu, and T.J. Anchordoquy Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells Mol. Pharm. 7 2010 1311 1317
36. S. Bhattacharya, and S. Haldar The effects of cholesterol inclusion on the vesicular membranes of cationic lipids Biochim. Biophys. Acta 1283 1996 21 30
37. R.M. Epand, D.W. Hughes, B.G. Sayer, N. Borochov, D. Bach, and E. Wachtel Novel properties of cholesterol-dioleoylphosphatidylcholine mixtures Biochim. Biophys. Acta 1616 2003 196 208
38. J.M. Smaby, H.L. Brockman, and R.E. Brown Cholesterol's interfacial interactions with sphingomyelins and phosphatidylcholines: hydrocarbon chain structure determines the magnitude of condensation Biochemistry 33 1994 9135 9142
39. X.B. Zhao, N. Muthusamy, J.C. Byrd, and R.J. Lee Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes J. Pharm. Sci. 96 2007 2424 2435
40. V.P. Torchilin, M.I. Shtilman, V.S. Trubetskoy, K. Whiteman, and A.M. Milstein Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo Biochim. Biophys. Acta 1195 1994 181 184
41. V.P. Torchilin, V.G. Omelyanenko, M.I. Papisov, A.A. Bogdanov Jr., V.S. Trubetskoy, J.N. Herron, and C.A. Gentry Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity Biochim. Biophys. Acta 1195 1994 11 20
42. S.D. Li, Y.C. Chen, M.J. Hackett, and L. Huang Tumor-targeted delivery of siRNA by self-assembled nanoparticles Mol. Ther. 16 2008 163 169
43. C.M. Paulos, M.J. Turk, G.J. Breur, and P.S. Low Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis Adv. Drug Deliv. Rev. 56 2004 1205 1217
44. L. Xu, and T. Anchordoquy Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics J. Pharm. Sci. 100 2011 38 52
45. K. Hong, W. Zheng, A. Baker, and D. Papahadjopoulos Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery FEBS Lett. 400 1997 233 237
46. L. Xu, M. Wempe, and T. Anchordoquy The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro Ther. Deliv. 2 2011 451 460